Singapore markets closed

Lyell Immunopharma, Inc. (LYEL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.7100-0.0500 (-1.81%)
At close: 04:00PM EDT
2.6500 -0.06 (-2.21%)
After hours: 04:27PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
68
130
84,683
10,650
7,756
-
Operating expenses
Research development
181,489
182,945
159,188
138,693
182,243
-
Selling general and administrative
61,198
66,983
117,307
89,057
46,881
-
Total operating expenses
240,095
247,138
271,741
225,426
219,693
-
Operating income or loss
-240,027
-247,008
-187,058
-214,776
-211,937
-
Total other income/expenses net
-14,088
-11,077
-3,113
-36,608
1,526
-
Income before tax
-228,340
-234,632
-183,118
-250,219
-204,472
-
Income from continuing operations
-228,340
-234,632
-183,118
-250,219
-204,472
-
Net income
-228,340
-234,632
-183,118
-250,219
-204,472
-
Net income available to common shareholders
-228,340
-234,632
-183,118
-250,219
-208,054
-
Basic EPS
-0.76
-
-0.74
-1.84
-0.98
-0.62
Diluted EPS
-0.76
-
-0.74
-1.84
-0.98
-0.62
Basic average shares
250,149
-
247,080
135,918
211,746
211,746
Diluted average shares
250,149
-
247,080
135,918
211,746
211,746